Eszopiclone
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Prescription non-benzodiazepine sedative-hypnotic (Schedule IV controlled substance) approved for insomnia. The S-isomer of zopiclone, it is one of the few prescription sleep aids approved for long-term use (no restriction on duration). Improves both sleep onset and sleep maintenance. Associated with an unpleasant metallic taste as a common side effect. Dosage must be determined by your prescribing physician.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Prescription non-benzodiazepine sedative-hypnotic (Schedule IV controlled substance) approved for insomnia. NutriStack rates the supporting evidence as strong. Common adult dosing is 1–3 mg at bedtime (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: improved sleep onset, improved sleep maintenance, approved for long-term use. 10 sources indexed (2014–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Binds to GABA-A receptors at or near the benzodiazepine binding site. While not as alpha-1 selective as zolpidem, it preferentially modulates GABA-A receptor subtypes involved in sleep initiation and maintenance. Its interaction with alpha-2 and alpha-3 subunits may contribute to anxiolytic and sleep-maintaining effects.6
Dosing & protocol.
Take immediately before bedtime on an empty stomach. Taking with or after a heavy, high-fat meal delays absorption. Allow at least 7–8 hours before planned awakening.2
Full safety detail.
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
4- 1Efficacy and safety of eszopiclone combined with drug therapy in the treatment of insomnia after stroke: A network meta-analysis and systematic reviewPMIDLi RY, Zhu DL, Chen KY · PloS one · 2024
Li RY, Zhu DL, Chen KY. Efficacy and safety of eszopiclone combined with drug therapy in the treatment of insomnia after stroke: A network meta-analysis and systematic review. PloS one. 2024
- 2Orexin dual receptor antagonists, zolpidem, zopiclone, eszopiclone, and cognitive research: A comprehensive dose-response meta-analysisPMIDZhou M, Tang J, Li S et al. · Frontiers in human neuroscience · 2022
Zhou M, Tang J, Li S et al.. Orexin dual receptor antagonists, zolpidem, zopiclone, eszopiclone, and cognitive research: A comprehensive dose-response meta-analysis. Frontiers in human neuroscience. 2022
- 3Eszopiclone for the treatment of primary insomnia: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trialsPMIDLiang L, Huang Y, Xu R et al. · Sleep medicine · 2019
Liang L, Huang Y, Xu R et al.. Eszopiclone for the treatment of primary insomnia: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials. Sleep medicine. 2019
- 4The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysisPMIDStranks EK, Crowe SF · Journal of clinical and experimental neuropsychology · 2014
Stranks EK, Crowe SF. The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis. Journal of clinical and experimental neuropsychology. 2014
Randomized controlled trials
1- 5Combination Drug Therapy with Acetazolamide, Eszopiclone ± Venlafaxine for Obstructive Sleep Apnea (RESCUE-Combo): A Randomized, Double-Blind, Placebo-controlled Clinical TrialPMIDSchmickl CN, Orr JE, Alex RM et al. · Annals of the American Thoracic Society · 2025
Schmickl CN, Orr JE, Alex RM et al.. Combination Drug Therapy with Acetazolamide, Eszopiclone ± Venlafaxine for Obstructive Sleep Apnea (RESCUE-Combo): A Randomized, Double-Blind, Placebo-controlled Clinical Trial. Annals of the American Thoracic Society. 2025
Reference material
5- 6Huedo-Medina TB et al. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the FDA. BMJ. 2012.Source linkedPMID
- 7Krystal AD et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep. 2003.Source linkedPMID
- 8Fuglsang NFB et al. Efficacy and Acceptability of Licensed and Off-Label Pharmacological Interventions for Insomnia in Patients With Severe Mental Illness: A Systematic Review and Meta-Analysis of Randomised Trials. Acta Psychiatr Scand. 2025.Source linkedPMID
- 9Harbourt K, Nevo ON, Zhang R et al.. Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death. Pharmacoepidemiology and drug safety. 2020Source linkedPMID
- 10Eszopiclone. 2006Source linkedPMID
Common questions.
Quick answers about Eszopiclone, drawn from the data on this page.
What is Eszopiclone?
Prescription non-benzodiazepine sedative-hypnotic (Schedule IV controlled substance) approved for insomnia. The S-isomer of zopiclone, it is one of the few prescription sleep aids approved for long-term use (no restriction on duration). Improves both sleep onset and sleep maintenance. Associated with an unpleasant metallic taste as a common side effect. Dosage must be determined by your prescribing physician.
What is Eszopiclone used for?
Commonly cited benefits of Eszopiclone include: Improved sleep onset; Improved sleep maintenance; Approved for long-term use; Reduced nighttime awakenings; Improved total sleep time. NutriStack rates the overall evidence as strong.
What is a typical dose of Eszopiclone?
A typical adult dose of Eszopiclone is 1–3 mg at bedtime (as prescribed by your physician). The commonly recommended form is Tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Eszopiclone?
Reported side effects include unpleasant metallic or bitter taste, headache, drowsiness, dizziness, dry mouth, next-day impairment. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Eszopiclone?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Eszopiclone in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.